These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 29296151

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, Hashiguchi L, Lim SS, Alam N.
    BMC Infect Dis; 2016 Aug 12; 16():411. PubMed ID: 27519586
    [Abstract] [Full Text] [Related]

  • 9. Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Oteri J, Idi Hussaini M, Bawa S, Ibizugbe S, Lambo K, Mogekwu F, Wiwa O, Seaman V, Kolbe-Booysen O, Braka F, Nsubuga P, Shuaib F.
    Vaccine; 2021 Nov 17; 39 Suppl 3():C29-C37. PubMed ID: 33478790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC, Mutembo S, Matakala KH, Chilumba I, Mulundu G, Monze M, Mwansa FD, Moss WJ, Hayford K.
    Am J Trop Med Hyg; 2021 May 03; 104(6):2229-2232. PubMed ID: 33939639
    [Abstract] [Full Text] [Related]

  • 14. Social capital, trust in health information, and acceptance of Measles-Rubella vaccination campaign in Tamil Nadu: A case-control study.
    Palanisamy B, Gopichandran V, Kosalram K.
    J Postgrad Med; 2018 May 03; 64(4):212-219. PubMed ID: 29943738
    [Abstract] [Full Text] [Related]

  • 15. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM, Sabbour SM, Dewedar SA.
    Vaccine; 2010 Nov 03; 28(47):7563-8. PubMed ID: 20797454
    [Abstract] [Full Text] [Related]

  • 20. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL, Grant GB, Moss WJ, Durrheim DN, Shefer A, Rota PA, Omer SB, Masresha BG, Mulders MN, Hanson M, Linkins RW, Goodson JL.
    Vaccine; 2019 Sep 10; 37(38):5745-5753. PubMed ID: 30898393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.